Capstone Investments Upgrades AMAG Pharmaceuticals (AMAG) to Buy
Tweet Send to a FriendGet Alerts AMAG Hot Sheet
Price: $22.40 -10.69%
Rating Summary:
7 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
7 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade AMAG Now!
Capstone Investments upgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Hold to Buy. PT $21.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.75 yesterday, with a 52 week range of $13.75-$45.61.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.75 yesterday, with a 52 week range of $13.75-$45.61.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- DA Davidson Upgrades Boise Cascade Company (BCC) to Neutral
- Morgan Stanley Upgrades Statoil ASA (STO) to Equalweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Capstone Investments
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
